Facial herpes zoster complicated by cerebral oedema in the course of encephalitis
, 3, 2, 2
Abstract
Herpes zoster is the result of the reactivation of the varicella-zoster virus (VZV), which remains dormant in the sensory ganglia. The clinical presentation is characterized by a unilateral vesicular rash occurring on an erythematous background and most commonly affecting one dermatome of the skin. An extremely rare complication of herpes zoster is encephalitis, which occurs in approximately 0.2% of cases. It involves fever, headache, nausea, vomiting, impaired consciousness, hallucinations, and balance disturbances in addition to the rash. The study presents a case of a 71-year-old female patient hospitalized in the Dermatology Clinic due to zoster on the left side of her face, accompanied by the above symptoms that occurred 2 days before admission and brain oedema observed in the head computed tomography, constituting the clinical picture of VZV-related encephalitis.
Keywords: herpes zostervaricella-zoster virusencephalitiscerebral oedema
References
- Kennedy PGE, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018; 10(11): 609.
- Ellis DA, Barsell A, Riahi R, et al. Varicella zoster virus encephalitis in a patient with disseminated herpes zoster: report and review of the literature. Dermatol Online J. 2015; 21(3).
- Skripuletz T, Pars K, Schulte A, et al. Varicella zoster virus infections in neurological patients: a clinical study. BMC Infect Dis. 2018; 18(1): 238.
- Tinnirello JM, Pecci MSR, Aguado Jd, et al. Edema cerebral difuso en una paciente con encefalopatía vascular por el virus de la varicela-zoster: una complicación inesperada [Mild cerebral oedema in a patient with vascular encephalopathy due to varicela-zoster virus: an unexpected complication]. Neurología. 2010; 25(2): 132–134.
- Rodrigues F, Santos M, Macedo E, et al. Varicella-Zoster virus: a case of encephalitis. Cureus. 2023; 15(9): e45378.
- Suzuki T, Tetsuka S, Ogawa T, et al. An autopsy case of varicella zoster virus encephalitis with multiple brain lesions. Intern Med. 2020; 59(13): 1643–1647.
- Lizzi J, Hill T, Jakubowski J. Varicella zoster virus encephalitis. Clin Pract Cases Emerg Med. 2019; 3(4): 380–382.
- Poscher ME. Successful treatment of varicella zoster virus meningoencephalitis in patients with AIDS: report of four cases and review. AIDS. 1994; 8(8): 1115–1117.
- Tattevin P, Schortgen F, de Broucker T, et al. Varicella-zoster virus limbic encephalitis in an immunocompromised patient. Scand J Infect Dis. 2001; 33(10): 786–788.
- De La Blanchardiere A, Rozenberg F, Caumes E, et al. Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection. Scand J Infect Dis. 2000; 32(3): 263–269.
- De Broucker T, Mailles A, Chabrier S, et al. steering committee and investigators group. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect. 2012; 18(8): 808–819.
- Ihekwaba UK, Kudesia G, McKendrick MW. Clinical features of viral meningitis in adults: significant differences in cerebrospinal fluid findings among herpes simplex virus, varicella zoster virus, and enterovirus infections. Clin Infect Dis. 2008; 47(6): 783–789.
- Becerra JC, Sieber R, Martinetti G, et al. Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis. 2013; 17(7): e529–e534.
- Persson A, Bergström T, Lindh M, et al. Varicella-zoster virus CNS disease — viral load, clinical manifestations and sequels. J Clin Virol. 2009; 46(3): 249–253.
- Aberle SW, Aberle JH, Steininger C, et al. Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol. 2005; 194(1–2): 7–12.
- Gilden D, Cohrs RJ, Mahalingam R, et al. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009; 8(8): 731–740.
